Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ciltacabtagene autoleucel 0.5 x 10exp6 to 1x 10exp8 cell IV suspension (OTHER 57894011101) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved October 29, 2026 , from http://ppman.hank.ai/transparency/procedure/57894011101/by-state?code_type=OTHER
“ciltacabtagene autoleucel 0.5 x 10exp6 to 1x 10exp8 cell IV suspension (OTHER 57894011101) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/57894011101/by-state?code_type=OTHER. Accessed
October 29, 2026 .
“ciltacabtagene autoleucel 0.5 x 10exp6 to 1x 10exp8 cell IV suspension (OTHER 57894011101) by State,” HANK Price Transparency ,
accessed October 29, 2026 ,
http://ppman.hank.ai/transparency/procedure/57894011101/by-state?code_type=OTHER.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
OTHER · across United States
57894011101 — Ciltacabtagene Autoleucel 0.5 X 10exp6 To 1x 10exp8 Cell IV Suspension
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$764,108
National median
$456,436 – $805,752
IQR (p25 – p75)
1
hospitals filing
1
states
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 57894011101 (OTHER), with interquartile range
State Median p25 p75
AR $764,108 $456,436 $805,752